CFMS Stock: Why Under-the-Radar Conformis Is on the Move
CFMS Stock: Why Under-the-Radar Conformis Is on the Move InvestorPlace 3/2/2021 Shares of medtech Conformis (NASDAQ: CFMS) surged more than 17% in pre-market trading on Tuesday after the company said it had received clearance in Australia for its total knee replacement system. CFMS stock has touched a 52-week high price of $1.48 per share twice since January. © Provided by InvestorPlace surgeons operating on a patient The patient-specific iTotal PS total knee replacement system, which was launched in the U.S. in 2016, got a green light for use down under by the Therapeutic Goods Adminis...
Source: msn.com